Chemoinformaics analysis of 4alpha-Methyl-5alpha-cholesta-7,24-dien-3beta-ol
| Molecular Weight | 398.675 | nRot | 4 |
| Heavy Atom Molecular Weight | 352.307 | nRig | 21 |
| Exact Molecular Weight | 398.355 | nRing | 4 |
| Solubility: LogS | -6.947 | nHRing | 0 |
| Solubility: LogP | 7.38 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 75 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 29 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 46 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 28 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 78.2345 |
| nHD | 1 | BPOL | 46.1475 |
| QED | 0.484 |
| Synth | 4.609 |
| Natural Product Likeliness | 3.156 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.045 |
| Pgp-sub | 0 |
| HIA | 0.03 |
| CACO-2 | -4.663 |
| MDCK | 0.00000697 |
| BBB | 0.898 |
| PPB | 0.995644 |
| VDSS | 3.021 |
| FU | 0.0165736 |
| CYP1A2-inh | 0.094 |
| CYP1A2-sub | 0.343 |
| CYP2c19-inh | 0.07 |
| CYP2c19-sub | 0.889 |
| CYP2c9-inh | 0.124 |
| CYP2c9-sub | 0.443 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.647 |
| CYP3a4-inh | 0.221 |
| CYP3a4-sub | 0.349 |
| CL | 21.485 |
| T12 | 0.008 |
| hERG | 0.025 |
| Ames | 0.019 |
| ROA | 0.139 |
| SkinSen | 0.035 |
| Carcinogencity | 0.034 |
| EI | 0.009 |
| Respiratory | 0.832 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.657982 |